MARKET

SEPN

SEPN

Septerna, Inc.
NASDAQ
25.41
+0.97
+3.97%
After Hours: 25.41 0 0.00% 16:10 02/06 EST
OPEN
24.73
PREV CLOSE
24.44
HIGH
25.76
LOW
24.13
VOLUME
280.13K
TURNOVER
--
52 WEEK HIGH
30.50
52 WEEK LOW
4.170
MARKET CAP
1.14B
P/E (TTM)
-16.8624
1D
5D
1M
3M
1Y
5Y
1D
Peakstone Realty Trust, Aquestive Therapeutics, Opera And Other Big Stocks Moving Higher On Monday
Benzinga · 5d ago
Weekly Report: what happened at SEPN last week (0126-0130)?
Weekly Report · 5d ago
Weekly Report: what happened at SEPN last week (0119-0123)?
Weekly Report · 01/26 09:45
MRNA is S&P 500’s top performing stock, here are the best Quant pharma companies
Seeking Alpha · 01/21 19:36
The Analyst Verdict: Septerna In The Eyes Of 6 Experts
Benzinga · 01/20 14:00
Septerna Price Target Raised to $35.00/Share From $30.00 by HC Wainwright & Co.
Dow Jones · 01/20 12:03
Septerna Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 01/20 12:03
HC Wainwright & Co. Maintains Buy on Septerna, Raises Price Target to $35
Benzinga · 01/20 11:53
More
About SEPN
Septerna, Inc. is a clinical-stage biotechnology company. The Company is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform. Its pipeline of product candidates is focused on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Its industrial-scale Native Complex Platform is designed to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to achieve desired therapeutic effects. It is advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with unmet needs. It is focused on therapeutic areas, such as neurology, women’s health, cardiovascular, and respiratory disease.

Webull offers Septerna, Inc. stock information, including NASDAQ: SEPN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SEPN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SEPN stock methods without spending real money on the virtual paper trading platform.